• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[脊髓灰质炎疫苗接种]

[Vaccination against poliomyelitis].

作者信息

Cellesi C, Rossolini A

出版信息

Pediatr Med Chir. 1984 Jan-Feb;6(1):13-5.

PMID:6099548
Abstract

The authors, after a review of some data about the actual poliomyelitis epidemiology in the world, point out the necessity of periodical checks for poliomyelitis vaccination. To this purpose, preliminary data of a research, undertaken in the province of Siena, into the effectiveness and innocuity of oral poliovirus vaccine, are reported. This evaluation has been made through isolation and identification of vaccinal polioviruses from stool after the first, second and then third dose of vaccine, and through titration of serum neutralizing antibodies. Results confirm the high effectiveness and innocuity of oral poliovirus vaccine, but suggest the opportuneness of some changes in the way of giving the oral vaccine.

摘要

作者在回顾了世界上有关脊髓灰质炎实际流行病学的一些数据后,指出了定期检查脊髓灰质炎疫苗接种情况的必要性。为此,报告了在锡耶纳省进行的一项关于口服脊髓灰质炎病毒疫苗有效性和安全性研究的初步数据。该评估是通过在接种第一剂、第二剂和第三剂疫苗后从粪便中分离和鉴定疫苗株脊髓灰质炎病毒,以及通过滴定血清中和抗体来进行的。结果证实了口服脊髓灰质炎病毒疫苗的高效性和安全性,但表明口服疫苗的接种方式有必要进行一些改变。

相似文献

1
[Vaccination against poliomyelitis].[脊髓灰质炎疫苗接种]
Pediatr Med Chir. 1984 Jan-Feb;6(1):13-5.
2
Poliomyelitis vaccination of infants: preimmunization status and seroconversion.婴儿脊髓灰质炎疫苗接种:免疫前状态及血清转化
Bull World Health Organ. 1973;48(2):195-8.
3
Immunogenicity of oral poliovirus vaccine administered in mass campaigns versus routine immunization programmes.在大规模疫苗接种运动与常规免疫规划中口服脊髓灰质炎疫苗的免疫原性。
Bull World Health Organ. 1995;73(6):769-77.
4
Poliomyelitis: epidemiology and prophylaxis. 4. Serological and virological surveys conducted after a mass vaccination campaign for the control of a threatening poliomyelitis epidemic.脊髓灰质炎:流行病学与预防。4. 在为控制一场有威胁的脊髓灰质炎疫情而开展大规模疫苗接种运动后进行的血清学和病毒学调查。
Bull World Health Organ. 1977;55(6):747-53.
5
The status of poliomyelitis in Venezuela.委内瑞拉的脊髓灰质炎状况。
Bull Pan Am Health Organ. 1974;8(1):66-71.
6
Evaluation of a two-dose administration of live oral poliovirus vaccine for wild and virulent vaccine-derived poliovirus type 1, 2, 3 strains in Japan.在日本对口服脊髓灰质炎减毒活疫苗两剂次接种针对1型、2型和3型野生脊髓灰质炎病毒及疫苗衍生强毒株的评估。
Scand J Infect Dis. 2008;40(3):247-53. doi: 10.1080/00365540701596003. Epub 2007 Sep 28.
7
[Excretion rates after Sabin oral vaccination against poliomyelitis in Tyrol].[蒂罗尔地区口服萨宾脊髓灰质炎疫苗后的排泄率]
Arch Hyg Bakteriol. 1968 Dec;152(5):410-4.
8
The maintaining of the active laboratory-based surveillance of the acute flaccid paralysis (AFP) cases in Romania in the framework of the strategic plan of the global polio eradication initiative.在全球根除脊髓灰质炎行动战略计划框架内,罗马尼亚对急性弛缓性麻痹(AFP)病例开展基于实验室的主动监测。
Roum Arch Microbiol Immunol. 2007 Jan-Jun;66(1-2):44-50.
9
Vaccine-associated paralytic poliomyelitis and other diseases with acute flaccid paralysis syndrome in Belarus.白俄罗斯的疫苗相关麻痹性脊髓灰质炎及其他伴有急性弛缓性麻痹综合征的疾病
Cent Eur J Public Health. 2003 Dec;11(4):213-8.
10
Poliomyelitis survey in Middle-East countries.中东国家的脊髓灰质炎调查。
Dev Biol Stand. 1978;41:149-58.

引用本文的文献

1
Poliomyelitis immunity status at different intervals from vaccination.不同疫苗接种间隔的脊髓灰质炎免疫状态
Eur J Epidemiol. 1986 Sep;2(3):197-204. doi: 10.1007/BF00211532.